Following the 2006 formation of the Dolomite Centre, the world's first microfluidic application centre, a new advisory group has been created to augment its scientific and fabrication expertise
The advisory group will significantly increase Dolomite's access to capabilities and application areas, with industry-leading professionals from sectors including pharmaceuticals, forensic science, medicine and academia.
With an in-depth understanding of chemistry and the life sciences combined with expertise in glass microfabrication and microfluidics, Dolomite offers a complete service, from device fabrication through to full instrument design and development.
With the incorporation of the new advisory group, Dolomite aims to make strategic decisions about where to apply its specialist glass, quartz and ceramic technologies and its high performance microfluidics knowledge.
The group members include: Julie Deacon, Micro and Nanotechnology (MNT) Network; Leonard Fass, GE Healthcare; Stephanie Hawkes, GlaxoSmithKline; Andy Hopwood, Forensic Science Service; Graeme Maxwell, Centre for Integrated Photonics (CIP); Andrew de Mello, Imperial College London; and Ian Sturland of BAE Systems.
Commenting on the formation of the advisory group, Dolomite managing director Mark Gilligan said, "The formation of this new group is of significant value for Dolomite and allows us to make strategic decisions about where best to use microfluidic technology to address novel application areas.
"The technology will address the current industry demands for improved reproducibility, faster performance and lower reagent consumption".
Dolomite was recently established as a subsidiary of Syrris , a leading UK developer of tools and technologies for R+D chemists.
Dolomite has been funded with a UK Department of Trade and Industry (Dti) grant of £2 million to become a new facility in the Dti's Micro and Nanotechnology (MNT) Facilities Network.
